Technologies
Title: | Medicinal Chemistry/synthesis of APIs/and repurposing of drugs |
Area: | Chemical Sciences, Medical Sciences, Pharmaceutical Sciences, Life Sciences & Biotechnology, COVID-19 Technology |
Focus Area: | Development of Repurposed Drugs for COVID-19 |
Developing Agency: | Central Drug Research Institute (CSIR-CDRI), Lucknow |
Technology Readiness Index: | Commercialized |
| Website Link : | https://www.cdri.res.in/Home.aspx |
Brief Description
Description : | The Lab has synthesised Niclosamide analogues for evaluation against Papain-like proteinase (PL-Pro) from Covid sars-2 and also other selected molecules for testing their inhibitory efficacy |